BG 89.15 Bunge Limited $BG Hit a 52 week high of 89.12

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 10:13 AM

BG 89.15 Bunge Limited $BG Hit a 52 week high of 89.12 Closing the day 09:45 at 89.15 +0.57 +0.64% With a day low of 88.33 and a total volume of 78,462.

BG Recent Posts: http://investorshangout.com/Bunge-Limited-BG-50276/

BG Bunge Limited Recent Headline News

Bunge Earnings Review: 18 Days after Announcement Shares Up 3.8% (BG)
Comtex SmarTrend(R) - 1 hr 12 mins ago
Two weeks ago on October 30th, 2014 Bunge (NYSE:BG) reported earnings and analysts, on average, expected earnings of $1.90 on sales of $15.2 billion. Bunge actually reported earnings of $1.31 per share on sales of $13.7 billion, missing EPS estimates by $0.59 and missing revenue estimates by $15,174.8 billion. Since the company's report, shares of Bunge have risen from $85.33 to $88.58, representing a gain of 3.8% in the past 18 days.
BG: 88.99 (+0.41)

Archer Daniels Expands in China, Opens Sweetener Facility - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 11:40AM CST
Archer Daniels Midland Company (ADM) inaugurated its previously announced sweetener facility in North China at the port of Tianjin, which overlooks the Yellow Sea.
BG: 88.99 (+0.41), ADM: 51.43 (+0.08), TSN: 41.54 (+0.88), ANFI: 15.86 (-0.14)

Solazyme Repositions Up The Value Chain Amidst Moema's Setback
Kevin Quon - at Seeking Alpha - Sun Nov 09, 10:59PM CST

E: 40.40 (-0.45), BG: 88.99 (+0.41), SZYM: 3.45 (-0.01)

Andersons (ANDE) Plunges as Q3 Earnings Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 3:20PM CST
The Andersons Inc. (ANDE) plunged 18% on reporting a 3% decline in Q3 earnings to 59 cents per share, way short of the Zacks Consensus Estimate of 76 cents.
BG: 88.99 (+0.41), CZZ: 8.80 (-0.20), LMNR: 25.75 (+0.19), ANDE: 54.80 (+0.35)

Archer Daniels Beats Q3 Earnings, Misses on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:20AM CST
Archer Daniels Midland Company (ADM) reported better-than-expected adjusted earnings per share for third-quarter 2014.
BG: 88.99 (+0.41), ADM: 51.43 (+0.08), CVGW: 45.68 (-0.19), ANFI: 15.86 (-0.14)

Companies Release Third Quarterly Results - Research Reports on Avon, BorgWarner, Kellogg, Hanes and Bunge
PR Newswire - Tue Nov 04, 8:15AM CST
Today, Analysts Review released its research reports regarding Avon Products, Inc. (NYSE: AVP), BorgWarner Inc. (NYSE: BWA), Kellogg Company (NYSE: K), HanesBrands Inc. (NYSE: HBI) and Bunge Ltd. (NYSE: BG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7685-100free.
BWA: 55.57 (+0.39), BG: 88.99 (+0.41), AVP: 10.01 (-0.06), HBI: 110.21 (+0.47), K: 64.19 (+0.38)

Grain companies face slowing crop sales, Bunge CEO says
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 1:25PM CDT

BG: 88.99 (+0.41)

Bunge Limited's (BG) CEO Soren Schroder on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 12:20PM CDT

BG: 88.99 (+0.41)

Bunge Limited (BG) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 8:55AM CDT

BG: 88.99 (+0.41)

Bunge misses Street 3Q forecasts
Automated Insights - Thu Oct 30, 7:01AM CDT
WHITE PLAINS, N.Y. (AP) _ Bunge Ltd. (BG) on Thursday reported earnings of $294 million in its third quarter.
BG: 88.99 (+0.41)

Bunge misses by $0.62, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:31AM CDT

BG: 88.99 (+0.41)

Bunge Reports Third Quarter 2014 Results
PR Newswire - Thu Oct 30, 5:30AM CDT
Bunge Limited (NYSE:BG)
BG: 88.99 (+0.41)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 59.08 (-0.04), HST: 22.61 (-0.06), CRR: 48.17 (-0.87), CAH: 80.65 (+0.30), AMT: 99.58 (+0.05), ACIW: 19.33 (+0.06), GTI: 4.28 (unch), IDA: 61.11 (+0.25), CRCM: 8.87 (+0.02), CVRR: 23.00 (-0.09), BGCP: 8.57 (+0.01), GOV: 23.05 (+0.08), DFT: 31.16 (unch), APO: 22.81 (-0.07), FIG: 7.67 (-0.07), AMAG: 34.94 (+0.94), HAR: 106.19 (-0.48), AVP: 10.01 (-0.06), EXLS: 28.42 (-0.19), INGR: 80.23 (-0.11), ALU: 3.11 (-0.01), INCY: 70.22 (+0.68), COP: 70.77 (-0.64), GEL: 48.26 (+0.30), COR: 38.34 (+0.41), GTLS: 42.95 (-0.07), BWA: 55.57 (+0.39), CARB: 11.71 (+0.16), GLOP: 23.08 (-0.08), IDCC: 50.26 (-0.43), HEES: 36.72 (unch), BCO: 21.39 (-0.11), DST: 99.66 (+0.26), EPD: 37.18 (-0.05), ABMD: 32.95 (-0.30), CEVA: 16.47 (-0.01), BLL: 64.24 (unch), GBX: 62.46 (-0.17), GNC: 42.93 (-0.41), CVI: 47.77 (+0.15), ACOR: 33.98 (+0.51), I: 17.85 (+0.01), FCN: 40.74 (-0.12), CRNT: 1.11 (+0.01), DHX: 11.44 (+0.04), BG: 88.99 (+0.41), CME: 84.39 (-0.43), FCH: 10.49 (+0.04), ALLE: 52.53 (+0.26), AUDC: 4.58 (-0.09), APD: 135.01 (+0.30), DBD: 34.94 (-0.06), HGG: 6.24 (+0.04), CBM: 23.38 (+0.21), CNSL: 27.57 (+0.40), ATK: 112.02 (+1.08), ANR: 2.52 (-0.08), CI: 102.07 (+0.17), ABC: 89.18 (+0.35), GG: 20.53 (+0.11)

3 Reasons Solazyme Inc. Stock Will Rise From All-Time Lows
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Oct 29, 1:15PM CDT
Volatility has taken hold of renewable-oils manufacturer Solazyme since it plunged to all-time lows of $5.54 per share earlier this month. One-day gains and losses of several percent have become the new normal as opportunistic investors exit short...
BG: 88.99 (+0.41), AMRS: 2.83 (-0.02), SZYM: 3.45 (-0.01)

Bunge (BG) Stock Downgraded to ‘Neutral’ at JPMorgan Today
at The Street - Tue Oct 28, 8:23AM CDT
Bunge (BG) stock was downgraded to 'neutral' from 'overweight' at JPMorgan.
BG: 88.99 (+0.41)

Downgrade Alert for Bunge (BG)
Comtex SmarTrend(R) - Tue Oct 28, 7:01AM CDT
Bunge (NYSE:BG) was downgraded from Overweight to Neutral at JP Morgan today. The stock closed yesterday at $83.82 on volume of 752,000 shares, below average daily volume of 1.0 million. Bunge (NYSE:BG) has potential upside of 7.9% based on a current price of $83.82 and analysts' consensus price target of $90.45. Bunge shares should encounter resistance at the 50-day moving average (MA) of $84.09 and support at its 200-day MA of $79.25.
BG: 88.99 (+0.41)

Andersons Buys 2 Grain Companies to Expand Corn Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 4:15PM CDT
Andersons (ANDE) has acquired the assets of United Grain and Keller Grain.
BG: 88.99 (+0.41), CZZ: 8.80 (-0.20), LMNR: 25.75 (+0.19), ANDE: 54.80 (+0.35)

Bear of the Day: AGCO (AGCO) - Bear of the Day
Tracey Ryniec - ZACKS - Mon Oct 20, 6:16AM CDT
Bear of the Day: AGCO (AGCO) - Bear of the Day
BG: 88.99 (+0.41), AGCO: 43.73 (-0.45)

Syngenta's Q3 Sales Rise Y/Y, 2014 Sales Growth Maintained - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:59AM CDT
Syngenta AG (SYT), after completing third-quarter 2014, has maintained its full year aggregated sales growth rate of 6%.
BG: 88.99 (+0.41), SYT: 64.87 (-0.04), LMNR: 25.75 (+0.19), ANDE: 54.80 (+0.35)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Supply Maverick Simplifies Global Shipping Processes

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Jari Spirits Set to Shake Up U.S. Market After Big Wins

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...